Cancer Research Technology
Log in Register
Menu

1, 2, 3-triazole-derived androgen receptor agonists (12a-f)
NEW

Info

Antigen/Gene or Protein Targets Androgen Receptors
Relevance These compounds present an excellent starting point for the development of prostate cancer therapeutics for both androgen dependent and independent forms of this disease. PMID: 25301770.
Molecular Formula Panel includes the following:
12a: C19H14F4N4NaO3S+
12b: C18H15F4N4O5S+
12c: C20H21FN3O5S+
12d: C18H17FN3O5S+
12e: C19H16F3N4O3S+
12f: C18H16F3N4O5S+
Molecular Weight (g/mol) 12a: 477.0643 12b: 475.0713 12c: 434.1162 12d: 406.0835 12e: 437.089 12f: 457.0728
Research Area Cancer

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Altimari et al. 2014. Bioorg Med Chem Lett. 24(21):4948-53. PMID: 25301770.


Add a reference

References: 1 entry

Altimari et al. 2014. Bioorg Med Chem Lett. 24(21):4948-53. PMID: 25301770.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor

Invented at